Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
BMS closes Redwood City cell therapy research site
Bristol Myers Squibb is closing a 256,000-square-foot research facility in Redwood City, CA as part of the company's larger restructuring.
Max Bayer
Apr 26, 2024 10:59am
BioMarin axes 4 candidates, centers R&D around 3 assets
Apr 25, 2024 10:10am
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 8:49am
Genentech axes $3B Adaptimmune cell therapy deal
Apr 12, 2024 11:22am
Poseida examines CAR-T conditioning to crack into solid tumors
Apr 10, 2024 10:32am
After knock back, BrainStorm aligns with FDA on ph. 3 ALS trial
Apr 9, 2024 7:51am
More News
Ex-bluebird execs hope to fly startup to delivery tech heights
Apr 9, 2024 7:00am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
Ring's new human viral vector delivers gene to retinas of mice
Apr 2, 2024 8:10am
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am
See more stories